Skip to main content
. 2020 May 14;7(4):1891–1899. doi: 10.1002/ehf2.12757

Table 1.

Population characteristics

Controls (n = 4185) Incident HF (n = 284) P a
Age (years) 57.17 ± 5.94 61.07 ± 4.84 7.34E−27
Sex, n (% women) 2572 (61.5) 134 (47.2) 1.91E−06
BMI (kg/m2) 25.56 ± 3.82 27.67 ± 4.77 1.20E−18
Fasting LDL‐C (mmol/L) 4.16 ± 0.98 4.20 ± 0.99 0.49
Fasting HDL‐C (mmol/L) 1.40 ± 0.37 1.30 ± 0.35 1.26E−05
SBP (mmHg) 140.28 ± 18.60 149.01 ± 20.01 3.25E−14
DBP (mmHg) 86.46 ± 9.22 89.82 ± 9.56 3.42E−09
NT‐proBNP (pg/mL) 93.18 ± 139.63 201.98 ± 576.71 5.28E−19
Diabetes prevalence, n (%) 286 (6.8) 51 (18.0) 6.41E−12
Antihypertensive medication use, n (%) 627 (15.0) 113 (39.8) 1.38E−27
Smoker, n (%) 1086 (26.0) 81 (28.6) 0.328

Values are displayed as M ± SD or frequency in per cent.

BMI, body mass index; DBP, diastolic blood pressure; HDL‐C, high‐density lipoprotein cholesterol; HF, heart failure; LDL‐C, low‐density lipoprotein cholesterol; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide; SBP, systolic blood pressure.

a

P values were obtained from Student's t‐tests for the continuous variables or from Pearson χ 2 tests for the binary variables.